A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL

NCT02046694 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia (ALL)

Interventions

DRUG: Allopurinol

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins